26 Jun 2025
// PRESS RELEASE
04 Jun 2025
// PRESS RELEASE
20 Mar 2025
// PRESS RELEASE
Innovating small molecule APIs & intermediates with top safety, quality, and agility, a reliable CDMO partner.
About
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #6.0B44
28-30 October, 2025
World Drug Safety EUWorld Drug Safety EU
Industry Trade Show
Not Confirmed
22-23 September, 2025
Industry Trade Show
Not Confirmed
25-26 September, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #6.0B44
28-30 October, 2025
World Drug Safety EUWorld Drug Safety EU
Industry Trade Show
Not Confirmed
22-23 September, 2025
Industry Trade Show
Not Confirmed
25-26 September, 2025
CORPORATE CONTENT #SupplierSpotlight
26 Jun 2025
// PRESS RELEASE
https://www.agcpharmachemicals.com/en/news/understanding-micronization-in-small-molecule-apis/
04 Jun 2025
// PRESS RELEASE
https://www.agcpharmachemicals.com/en/news/jun-kurihara-new-ceo-of-agc-pharma-chemicals/
20 Mar 2025
// PRESS RELEASE
https://www.agcpharmachemicals.com/en/news/agc-pharma-chemicals-recognized-as-the-best-manufacturing-capabilities-at-the-cdmo-leadership-awards-2025/
29 Jan 2025
// PRESS RELEASE
https://www.agcpharmachemicals.com/en/news/agc-pharma-chemicals-announces-expansion-of-hpapi-capabilities-in-barcelona/
22 Jan 2025
// PRESS RELEASE
https://www.agcpharmachemicals.com/en/news/agc-pharma-chemicals-first-and-only-cdmo-in-spain-recognized-as-a-top-employer/
24 Jul 2024
// PRESS RELEASE
https://www.agcpharmachemicals.com/en/news/carbon-footprint-and-cdmos-how-is-agc-pharma-chemicals-addressing-it/
VMF Number : 5897
Submission : 2007-06-15
Status : Active
Type : II
Registrant Name : IMCD Korea Co., Ltd.
Registration Date : 2021-09-28
Registration Number : 20210325-209-J-909(1)
Manufacturer Name : AGC Pharma Chemicals Europe SLU
Manufacturer Address : Cami de la Pomereda, 13, 08380 Malgrat de Mar, Barcelona, Spain
Registrant Name : Boehringer Ingelheim Korea Ltd.
Registration Date : 2021-03-25
Registration Number : 20210325-209-J-909
Manufacturer Name : AGC Pharma Chemicals Europe SLU
Manufacturer Address : Camí de la Pomereda, 13, 08380 Malgrat de Mar, Barcelona, Spain
Details:
The collaboration aims for the development of an API for the treatment of pancreatic cancer, ABTL0812 (ibrilatazar), currently in clinical trials.
Lead Product(s): Ibrilatazar,Inapplicable
Therapeutic Area: Oncology Brand Name: ABTL0812
Study Phase: Phase I/ Phase IIProduct Type: Other Small Molecule
Sponsor: Ability Pharma
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration July 16, 2024
Lead Product(s) : Ibrilatazar,Inapplicable
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Partner/Sponsor/Collaborator : Ability Pharma
Deal Size : Undisclosed
Deal Type : Collaboration
AGC Pharma and AbilityPharma to Produce Innovative Treatment for Pancreatic Cancer
Details : The collaboration aims for the development of an API for the treatment of pancreatic cancer, ABTL0812 (ibrilatazar), currently in clinical trials.
Product Name : ABTL0812
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
July 16, 2024
Services
Analytical
API Manufacturing
API & Drug Product Development
ABOUT THIS PAGE
AGC Pharma Chemicals Europe is a supplier offers 6 products (APIs, Excipients or Intermediates).
Find a price of Dipyridamole bulk offered by AGC Pharma Chemicals Europe
Find a price of Gliquidone bulk offered by AGC Pharma Chemicals Europe
Find a price of Mexiletine bulk offered by AGC Pharma Chemicals Europe
Find a price of Pimobendan bulk offered by AGC Pharma Chemicals Europe
Find a price of Pirenzepine bulk offered by AGC Pharma Chemicals Europe
Find a price of Telmisartan bulk offered by AGC Pharma Chemicals Europe